Showing results (131-140 of 250) with videos related to

Sort By:
Pageof 25
The Pediatric Infectious Disease Journal|March 1, 1990
Studies on Pneumococcus vaccine alone or mixed with DTP and on Pneumococcus type 6B and Haemophilus influenzae type b capsular polysaccharide-tetanus toxoid conjugates in two- to five-year-old children with sickle cell anemiaS Sarnaik, J Kaplan, G Schiffman, et al.
International Archives of Allergy and Applied Immunology|January 1, 1987
Effect of cocaine on the immune response and host resistance in BALB/c miceH F Havas, M Dellaria, G Schiffman, et al.
Chest|June 1, 1989
Serious infectious complications of corticosteroid therapy for COPDP M Wiest, T Flanigan, R A Salata, et al.
Journal of Acquired Immune Deficiency Syndromes|July 1, 1994
Mycobacterium tuberculosis and its purified protein derivative activate expression of the human immunodeficiency virusM M Lederman, D L Georges, D J Kusner, et al.
American Journal of Diseases of Children (1960)|April 1, 1985
Maternal-fetal transfer of pneumococcal capsular polysaccharide antibodiesD S Chudwin, D W Wara, G Schiffman, et al.
The New England Journal of Medicine|July 24, 1980
Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigensG R Siber, P H Schur, A C Aisenberg, et al.
Reviews of Infectious Diseases|March 1, 1981
Immunization of immunosuppressed patients with pneumococcal polysaccharide vaccineA J Ammann, G Schiffman, J E Addiego, et al.
Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)|September 1, 1986
Pneumococcal vaccine immunization of patients with renal impairmentM W Rytel, M P Dailey, G Schiffman, et al.
The Journal of Pediatrics|October 1, 1995
Anti-pneumococcal antibody levels three to seven years after first booster immunization in children with sickle cell disease, and after a second boosterS P Rao, K Rajkumar, G Schiffman, et al.
The Journal of Infectious Diseases|November 1, 1989
Response to pneumococcal vaccine among asymptomatic heterosexual partners of persons with AIDS and intravenous drug users infected with human immunodeficiency virusR S Klein, P A Selwyn, D Maude, et al.
Pageof 25